E-LIB Suche - Ergebnisse für: Buzzatti, Elisa

1

Evans syndrome: Disease awareness and clinical management i..:

Fattizzo, Bruno ; Carrai, Valentina ; Crugnola, Monica...
European Journal of Haematology. , 2024

2

ACUTE LEUKEMIA AND LATENT TUBERCULOSIS INFECTION IN ITALY: ..:

Nunzi, Andrea ; Della Valle, Luigi ; Lindfors Rossi, Elisa Linnea...
Mediterranean Journal of Hematology and Infectious Diseases. 16 (2024) 1 - p. e2024054 , 2024

Link: https://doi.org/10.4084/..

3

The ISTH DIC-score predicts early mortality in patients wit..:

Paterno, Giovangiacinto ; Palmieri, Raffaele ; Tesei, Cristiano...
Thrombosis Research. 236 (2024) - p. 30-36 , 2024

Link: https://doi.org/10.1016/..

4

FEVER OF UNKNOWNORIGIN AND MULTIDRUG-RESISTANT ORGANISMS CO..:

Guarnera, Luca ; Trotta, Gentiana Elena ; Boldrini, Valentina...
Mediterranean Journal of Hematology and Infectious Diseases. 15 (2023) 1 - p. e2023013 , 2023

Link: https://doi.org/10.4084/..

5

PB2611: EVANS SYNDROME: DISEASE AWARENESS AND CLINICAL MANA..:

Fattizzo, Bruno ; Carrai, Valentina ; Crugnola, Monica...
HemaSphere. 7 (2023) S3 - p. e024400a , 2023

Link: https://doi.org/10.1097/..

6

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for t..:

Fracchiolla, Nicola Stefano ; Sciumè, Mariarita ; Papayannidis, Cristina...
Cancers. 15 (2023) 18 - p. 4623 , 2023

Link: https://doi.org/10.3390/..

7

Real-life experience of secondary prophylaxis with DOACs in..:

Guarnera, Luca ; Buzzatti, Elisa ; Bonanni, Fabrizio...
Annals of Hematology. 102 (2023) 6 - p. 1607-1608 , 2023

Link: https://doi.org/10.1007/..

8

Prospective multicenter study on infectious complications a..:

Candoni, Anna ; Lazzarotto, Davide ; Papayannidis, Cristina...
American Journal of Hematology. 98 (2023) 4 - p. , 2023

Link: https://doi.org/10.1002/..

9

Measurable Residual Disease (MRD) as a Surrogate Efficacy-R..:

Meddi, Elisa ; Savi, Arianna ; Moretti, Federico...
International Journal of Molecular Sciences. 24 (2023) 4 - p. 3062 , 2023

Link: https://doi.org/10.3390/..

10

Measurable Residual Disease (MRD) as a Surrogate Efficacy-R..:

Meddi, Elisa ; Savi, Arianna ; Moretti, Federico...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967250/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for t..:

Nicola Stefano Fracchiolla ; Mariarita Sciumè ; Cristina Papayannidis...
https://www.mdpi.com/2072-6694/15/18/4623. , 2023

Link: https://doi.org/10.3390/..

12

PB2611: EVANS SYNDROME: DISEASE AWARENESS AND CLINICAL MANA..:

Bruno Fattizzo ; Valentina Carrai ; Monica Crugnola...
http://journals.lww.com/10.1097/01.HS9.0000977132.02440.0a. , 2023

Link: https://doi.org/10.1097/..

13

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for t..:

Fracchiolla, Nicola Stefano ; Sciumè, Mariarita ; Papayannidis, Cristina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526797/. , 2023

Link: http://www.ncbi.nlm.nih...

14

FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS C..:

Guarnera, Luca ; Trotta, Gentiana Elena ; Boldrini, Valentina...
info:eu-repo/semantics/altIdentifier/pmid/36660358. , 2023

Link: https://hdl.handle.net/2..

15

Measurable Residual Disease (MRD) as a Surrogate Efficacy-R..:

Elisa Meddi ; Arianna Savi ; Federico Moretti...
Molecular Biology. , 2023

Link: https://doi.org/10.3390/..